| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07addebfc9446dc5a9a77692ebf4dac1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ac75749f78c04898e32024f2f5320c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_747ba3a5fa0e8f6c96561d5815571319
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_148e4393503c48409227e5a4d8b4668c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f53a0242fcd439bb9c6faa22cc108d1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98a753c736373ec3e26fb0ef5603ee74 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 |
| filingDate |
2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4306463191ec37cca8fbc91c820fb90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1d0fdc63f03c9e2c98d37a8d5eabd5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c8917c4bb63fd82e5aceaac352ee5b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60b9dde4fade19a4065b68027252d13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_099e141840c955dd6319c49af9b6de5d |
| publicationDate |
2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009129094-A2 |
| titleOfInvention |
Compositions containing antiviral compounds and methods of using the same |
| abstract |
The present invention is directed to compositions and methods for the treatment of various diseases, pathological disorders, and medical conditions such as viral infections and cancer. The compositions include (A) an antiviral compound or a pharmaceutically acceptable salt thereof; and (B) an agent selected from the group consisting of a substituted or unsubstituted imidazole or a pharmaceutically acceptable salt thereof; a non-steroidal anti inflammatory agent or a pharmaceutically acceptable salt thereof; an amino acid or a pharmaceutically acceptable salt thereof; a carboxylic acid or a pharmaceutically acceptable salt thereof; a sulfonic acid or a pharmaceutically acceptable salt thereof; and a combination thereof. |
| priorityDate |
2008-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |